These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21571026)

  • 1. Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.
    Wang X; Cohn A; Comanducci M; Andrew L; Zhao X; MacNeil JR; Schmink S; Muzzi A; Bambini S; Rappuoli R; Pizza M; Murphy E; Hoiseth SK; Jansen KU; Anderson AS; Harrison LH; Clark TA; Messonnier NE; Mayer LW
    Vaccine; 2011 Jun; 29(29-30):4739-44. PubMed ID: 21571026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic characterization and estimated 4CMenB vaccine strain coverage of 284
    Efron A; Brozzi A; Biolchi A; Bodini M; Giuliani M; Guidotti S; Lorenzo F; Moscoloni MA; Muzzi A; Nocita F; Pizza M; Rappuoli R; Tomei S; Vidal G; Vizzotti C; Campos J; Sorhouet Pereira C
    Hum Vaccin Immunother; 2024 Dec; 20(1):2378537. PubMed ID: 39037011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Neisseria meningitidis serogroup b (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009-2014, prior to NmB vaccine licensure.
    Chang HY; Vuong J; Hu F; Liberator P; Chen A; Kretz CB; Blain A; Hao L; Retchless AC; Whaley MJ; Anderson AS; Wang X
    J Infect; 2019 Nov; 79(5):426-434. PubMed ID: 31505201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups.
    Hoiseth SK; Murphy E; Andrew L; Vogel U; Frosch M; Hellenbrand W; Abad R; Vazquez JA; Borrow R; Findlow J; Taha MK; Deghmane AE; Caugant DA; Kriz P; Musilek M; Mayer LW; Wang X; Macneil JR; York L; Tan CY; Jansen KU; Anderson AS
    Pediatr Infect Dis J; 2013 Oct; 32(10):1096-101. PubMed ID: 23694830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa.
    Mothibeli KM; du Plessis M; von Gottberg A; Murphy E; Hoiseth SK; Zlotnick G; Klugman KP
    Vaccine; 2011 Mar; 29(11):2187-92. PubMed ID: 21144918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine.
    Rossi R; Beernink PT; Giuntini S; Granoff DM
    Clin Vaccine Immunol; 2015 Dec; 22(12):1227-34. PubMed ID: 26424832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure.
    Wang X; Shutt KA; Vuong JT; Cohn A; MacNeil J; Schmink S; Plikaytis B; Messonnier NE; Harrison LH; Clark TA; Mayer LW
    J Infect Dis; 2015 Jun; 211(12):1887-94. PubMed ID: 25556253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.
    Murphy E; Andrew L; Lee KL; Dilts DA; Nunez L; Fink PS; Ambrose K; Borrow R; Findlow J; Taha MK; Deghmane AE; Kriz P; Musilek M; Kalmusova J; Caugant DA; Alvestad T; Mayer LW; Sacchi CT; Wang X; Martin D; von Gottberg A; du Plessis M; Klugman KP; Anderson AS; Jansen KU; Zlotnick GW; Hoiseth SK
    J Infect Dis; 2009 Aug; 200(3):379-89. PubMed ID: 19534597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets.
    Law DK; Lefebvre B; Gilca R; Deng S; Zhou J; De Wals P; Tsang RS
    BMC Microbiol; 2015 Jul; 15():143. PubMed ID: 26204985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014.
    Bukovski S; Vacca P; Anselmo A; Knezovic I; Fazio C; Neri A; Ciammaruconi A; Fortunato A; Palozzi AM; Fillo S; Lista F; Stefanelli P
    J Med Microbiol; 2016 Sep; 65(9):1013-1019. PubMed ID: 27452726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Neisseria meningitidis isolates causing fatal disease.
    Jacobsson S; Olcén P; Löfdahl M; Fredlund H; Mölling P
    Scand J Infect Dis; 2008; 40(9):734-44. PubMed ID: 19086340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec.
    Gilca R; De Wals P; Nolan SM; Kitchin N; Eiden JJ; Jiang Q; Jones CH; Jansen KU; Anderson AS; Pedneault L
    mSphere; 2018 Dec; 3(6):. PubMed ID: 30518675
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa.
    Ganesh K; Allam M; Wolter N; Bratcher HB; Harrison OB; Lucidarme J; Borrow R; de Gouveia L; Meiring S; Birkhead M; Maiden MC; von Gottberg A; du Plessis M
    BMC Microbiol; 2017 Feb; 17(1):40. PubMed ID: 28222677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales.
    Lucidarme J; Comanducci M; Findlow J; Gray SJ; Kaczmarski EB; Guiver M; Kugelberg E; Vallely PJ; Oster P; Pizza M; Bambini S; Muzzi A; Tang CM; Borrow R
    J Clin Microbiol; 2009 Nov; 47(11):3577-85. PubMed ID: 19759227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines.
    Muzzi A; Bodini M; Topaz N; Masignani V; Vadivelu K; Marjuki H; Wang X; Serino L; Medini D
    mSphere; 2022 Oct; 7(5):e0038522. PubMed ID: 36129279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China.
    Zhu B; Shi F; Zhang A; Sun X; Xu Z; Xu L; Gao Y; Lv J; Shao Z
    Vaccine; 2018 Apr; 36(15):1983-1989. PubMed ID: 29523451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal Antigen Typing System (MATS)-Based
    Rajam G; Stella M; Kim E; Paulos S; Boccadifuoco G; Serino L; Carlone G; Medini D
    mSphere; 2017; 2(6):. PubMed ID: 29152576
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor H binding protein (FHbp): An evaluation of genotypic diversity across
    Li Z; Murthy AK; Hao L; Andrew L; Anderson AS
    Hum Vaccin Immunother; 2024 Dec; 20(1):2409502. PubMed ID: 39387286
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of factor H Binding Protein sub-variants among Neisseria meningitidis in China.
    Shi F; Zhang A; Zhu B; Gao Y; Xu L; Li Y; Yin Z; Li J; Xie N; Shao Z
    Vaccine; 2017 Apr; 35(18):2343-2350. PubMed ID: 28351732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(46):1010-3. PubMed ID: 8965799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.